您的位置: 首页 > 2022年1月 第52卷 第1期 > 文字全文
2023年7月 第38卷 第7期11
目录

富血小板血浆联合髓芯减压治疗早期膝关节自发性骨坏死的疗效

Effect of platelet-rich plasma combined with core decompression in the treatment of early spontaneous osteonecrosis of the knee

来源期刊: 广州医药 | 45-49 发布时间:2022-04-12 收稿时间:2025/11/13 18:26:09 阅读量:10
作者:
关键词:
富血小板血浆髓芯减压自发性骨坏死膝关节
platelet-rich plasmacore decompressionspontaneous osteonecrosisknee joint
DOI:
10.3969/j.issn.1000-8535.2022.01.009
收稿时间:
2021-07-12 
修订日期:
 
接收日期:
 
引用总数:
3  
目的 探讨富血小板血浆(platelet-rich plasma, PRP)联合髓芯减压治疗早期膝关节自发性骨坏死(spontaneous osteonecrosis of the knee, SONK)的临床疗效。方法 回顾性分析我院2015年6月—2020年6月收治Koshino分期为Ⅰ、Ⅱ期的SONK患者,按治疗方法不同分为单纯髓芯减压组(对照组 21例)和PRP注射+髓芯减压组(PRP组 22例),比较2组患者治疗前、后1月、3月、6月、12月的VAS评分、WOMAC评分,评估术前和随访时膝关节功能,并观察记录有无并发症。结果 43例患者术后随访12~62个月,2组患者治疗后均无切口感染、关节感染、深静脉血栓等并发症。2组患者术前VAS评分、WOMAC评分比较无统计学意义(P>0.05);VAS评分、WOMAC评分在术后1、3、6 、12月较术前比较差异均有统计学意义(P<0.05);与对照组相比,PRP组术后3、6、12月的VAS评分降低(P<0.05),PRP组在术后6、12月的WOMAC评分改善(P<0.05)。PRP组、对照组的总体有效率分别为90.48%(19/21)、77.27%(17/22),差异有统计学意义(P<0.05)。在完成治疗12个月后至今的随访中,对照组共有6例患者、PRP组仅2例患者行单髁置换。结论 富血小板血浆联合髓芯减压治疗早期SONK,安全有效,临床疗效优于单纯髓芯减压术。
Objective To investigate the clinical effect of platelet-rich plasma(PRP) combined with core decompression in the treatment of early spontaneous osteonecrosis of the knee(SONK). Methods A retrospective analysis of SONK patients with Koshino stage I and Ⅱ admitted to our hospital from June 2015 to June 2020 was carried out. According to the different treatment methods, patients were divided into core decompression group (control group, 21 patients), and knee joint cavity PRP injection combined with core decompression group (PRP group, 22 patients). The VAS scores and WOMAC scores before treatment, 1, 3, 6 and 12 months after surgery were compared between the two groups to assess the knee joint function, and observed whether there were complications. Results Forty-three patients were followed up for 12 to 62 months after the operation. After treatment, the two groups had no complications such as wound infection, joint infection, or deep vein thrombosis. The preoperative VAS score and WOMAC score of the two groups were not significantly different (P>0.05);compared with those before the operation, VAS score and WOMAC score were significantly different at 1, 3, 6, and 12 months after the operation (P<0.05); compared with the control group, the VAS score of the PRP group was significantly reduced at 3, 6, and 12 months after surgery (P<0.05), and the WOMAC score of the PRP group was significantly improved at 6 and 12 months after surgery (P<0.05). The overall effective rates of the PRP group and the control group were 90.48% (19/21) and 77.27% (17/22) respectively, and the difference between the two groups was statistically significant (P<0.05). In the follow-up 12 months after the completion of the treatment, 6 patients in the control group and 2 patients in the PRP group underwent unicondylar replacement. Conclusion The combination of platelet-rich plasma and core decompression in the treatment of early SONK was safe and effective, and the clinical effect was better than that of core decompression only.
1、 CHEN Z, WANG C, YOU D, et al. Platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a Meta-analysis[J]. Medicine, 2020,99(11):e19388. CHEN Z, WANG C, YOU D, et al. Platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: a Meta-analysis[J]. Medicine, 2020,99(11):e19388.
2、 BELK J W, KRAEUTLER M J, HOUCK D A, et al. Platelet-richplasma versus hyaluronic acid for knee osteoarthritis: a systematic review and Meta-analysis of randomized controlled trials[J]. Am J Sports Med, 2021,49(1):249-260. BELK J W, KRAEUTLER M J, HOUCK D A, et al. Platelet-richplasma versus hyaluronic acid for knee osteoarthritis: a systematic review and Meta-analysis of randomized controlled trials[J]. Am J Sports Med, 2021,49(1):249-260.
3、 DAI W L, ZHOU A G, ZHANG H, et al. Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: a Meta-analysis of randomized controlled trials[J]. Arthroscopy, 2017,33(3):659-670. DAI W L, ZHOU A G, ZHANG H, et al. Efficacy of platelet-rich plasma in the treatment of knee osteoarthritis: a Meta-analysis of randomized controlled trials[J]. Arthroscopy, 2017,33(3):659-670.
4、 AKGUN I, KESMEZACAR H, OGUT T, et al. Arthroscopic microfracture treatment for osteonecrosis of the knee[J]. Arthroscopy, 2005,21(7):834-843. AKGUN I, KESMEZACAR H, OGUT T, et al. Arthroscopic microfracture treatment for osteonecrosis of the knee[J]. Arthroscopy, 2005,21(7):834-843.
5、 FORST J, FORST R, HELLER K D, et al. Spontaneous osteonecrosis of the femoral condyle: causal treatment by early core decompression[J]. Arch Orthop Trauma Surg, 1998,117(1-2):18-22. FORST J, FORST R, HELLER K D, et al. Spontaneous osteonecrosis of the femoral condyle: causal treatment by early core decompression[J]. Arch Orthop Trauma Surg, 1998,117(1-2):18-22.
6、 王浩浩, 张民, 席刚, 等. 膝关节自发性骨坏死的保膝治疗研究进展[J]. 实用骨科杂志, 2020,26(12):1127-1131. 王浩浩, 张民, 席刚, 等. 膝关节自发性骨坏死的保膝治疗研究进展[J]. 实用骨科杂志, 2020,26(12):1127-1131.
7、 WU W, CHEN F, LIU Y, et al. Autologous injectable tissue-engineered cartilage by using platelet-rich plasma: experimental study in a rabbit model[J]. J Oral Maxillofac Surg, 2007,65(10):1951-1957. WU W, CHEN F, LIU Y, et al. Autologous injectable tissue-engineered cartilage by using platelet-rich plasma: experimental study in a rabbit model[J]. J Oral Maxillofac Surg, 2007,65(10):1951-1957.
8、 中国医疗保健国际交流促进会骨科分会, 邢丹, 余楠生, 等. 关节腔注射富血小板血浆治疗膝骨关节炎的临床实践指南(2018年版)[J]. 中华关节外科杂志(电子版), 2018(4):444-448. 中国医疗保健国际交流促进会骨科分会, 邢丹, 余楠生, 等. 关节腔注射富血小板血浆治疗膝骨关节炎的临床实践指南(2018年版)[J]. 中华关节外科杂志(电子版), 2018(4):444-448.
9、 KON E, FILARDO G, DELCOGLIANO M, et al. Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper's knee[J]. Injury, 2009,40(6):598-603. KON E, FILARDO G, DELCOGLIANO M, et al. Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper's knee[J]. Injury, 2009,40(6):598-603.
10、 刘新光, 郭万首. 自发性膝关节骨坏死的治疗进展[J]. 中华骨与关节外科杂志, 2015,8(4):363-366. 刘新光, 郭万首. 自发性膝关节骨坏死的治疗进展[J]. 中华骨与关节外科杂志, 2015,8(4):363-366.
11、 DEIE M, OCHI M, ADACHI N, et al. Artificial bone grafting[calcium hydroxyapatite ceramic with an interconnected porous structure (IP-CHA)] and core decompression for spontaneous osteonecrosis of the femoral condyle in the knee[J]. Knee Surg Sports Traumatol Arthrosc, 2008,16(8):753-758. DEIE M, OCHI M, ADACHI N, et al. Artificial bone grafting[calcium hydroxyapatite ceramic with an interconnected porous structure (IP-CHA)] and core decompression for spontaneous osteonecrosis of the femoral condyle in the knee[J]. Knee Surg Sports Traumatol Arthrosc, 2008,16(8):753-758.
12、 AHLBACK S, BAUER G C, BOHNE W H. Spontaneous osteonecrosis of the knee[J]. Arthritis Rheum, 1968,11(6):705-733. AHLBACK S, BAUER G C, BOHNE W H. Spontaneous osteonecrosis of the knee[J]. Arthritis Rheum, 1968,11(6):705-733.
1、万芃聪.生物材料联合髓芯减压治疗早期膝关节自发性骨坏死[D].广州中医药大学,2024.DOI:10.27044/d.cnki.ggzzu.2024.000671. 万芃聪.生物材料联合髓芯减压治疗早期膝关节自发性骨坏死[D].广州中医药大学,2024.DOI:10.27044/d.cnki.ggzzu.2024.000671.
2、刘晓岚.MRI征象在膝关节软骨下骨不全骨折鉴别及分级诊断中的价值[D].右江民族医学院,2025.DOI:10.27908/d.cnki.gymzy.2025.000218. 刘晓岚.MRI征象在膝关节软骨下骨不全骨折鉴别及分级诊断中的价值[D].右江民族医学院,2025.DOI:10.27908/d.cnki.gymzy.2025.000218.
3、潘芹,李小丹,伍星.富血小板血浆联合关节镜治疗Ⅲ度半月板损伤膝关节功能恢复时间的影响因素分析[J].广州医药,2024,55(06):663-669. 潘芹,李小丹,伍星.富血小板血浆联合关节镜治疗Ⅲ度半月板损伤膝关节功能恢复时间的影响因素分析[J].广州医药,2024,55(06):663-669.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录